v3.26.3
Financial Income, Net - Schedule of Financial Income, Net (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revaluation of investments:        
Financial income, net $ 30,544 $ 60,961 $ 178,912 $ 72,242
Revaluation of Marketable Securities 147 2,686 (1,911) 2,786
Loan extension fee income – Scilex 1,000 1,000
Interest Income 150 510 524 2,135
Exchange rate (81) (8) (127) 106
Other 284 7 180 (205)
Revaluation of investments, net 31,897 61,470 180,489 74,278
Revaluation of Scilex, net [Member]        
Revaluation of investments:        
Financial income, net (5,895) 34,163 (3,428) 38,457
Revaluation of Hapisga, net [Member]        
Revaluation of investments:        
Financial income, net (537) 418 9,441 853
Revaluation of Alpha Tau, net [Member]        
Revaluation of investments:        
Financial income, net 41,083 22,306 174,500 29,691
Revaluation of RoyaltyVest loan, net [Member]        
Revaluation of investments:        
Financial income, net (444) 1,324 (549) 294
Revaluation of Profit Sharing Loan Agreement [Member]        
Revaluation of investments:        
Financial income, net 196 64 193 161
Revaluation of Ruby Capital [Member]        
Revaluation of investments:        
Financial income, net (15) (50)
Revaluation of Lifeward [Member]        
Revaluation of investments:        
Financial income, net [1] (3,927) 1,140
Revaluation of 83 Wythe Loan and Warren at Bay Loan [Member]        
Revaluation of investments:        
Financial income, net $ (64) $ (424)
[1]
(1) For the nine months ended September 30, 2026, includes revaluation gains of $88 on the Lifeward shares and $3,655 on the Lifeward warrants, offset by a revaluation loss of $1,144 on the Initial Note and a loss of $1,459 recognized upon the conversion of the Secured Promissory Note and the additional note into the Initial Note.

 

For the three months ended September 30, 2026, includes revaluation losses of $1,325 on the Lifeward shares and $1,448 on the Lifeward warrants, and a revaluation loss of $1,154 on the Initial Note (see note 8).